Hims & Hers price target raised to $29 from $25 at Barclays
Barclays analyst Glen Santangelo raised the firm’s price target on Hims & Hers to $29 from $25 and keeps an Overweight rating on the shares. The rally post the Novo Nordisk agreement highlights the incremental market opportunity and removal of the legal overhang for Hims & Hers shares, the analyst tells investors in a research note. Barclays believes the market is still underappreciating Hims’ opportunity from new products.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
See Insiders’ Hot Stocks on TipRanks >>
Read More on HIMS:
- HIMS-Novo ‘Can’t Quit Each Other’ – Bulls Rally on Wegovy Deal
- Hims & Hers names Kathryn Beiser as Chief Communications Officer
- Hims & Hers rises 12.0%
- Unusually active option classes on open March 10th
- Qualcomm downgraded, Rivian upgraded: Wall Street’s top analyst calls
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
LAZARD, INC. <LAZ.N>: KBW CUTS TARGET PRICE TO $39.00 FROM $42.00
LAZARD, INC. : KBW CUTS TARGET PRICE TO $39.00 FROM $42.00
What Stocks Will Shine When the AI Bubble Bursts? John Rogers Says Look to Smucker's
GFL ENVIRONMENTAL INC. <GFL.TO>: CIBC CUTS TARGET PRICE TO C$77 FROM C$82
GFL ENVIRONMENTAL INC. : CIBC CUTS TARGET PRICE TO C$77 FROM C$82
Gold edges higher after hitting a two-month low
Crypto prices
More
